Cytosorbents (CTSO) Other Non-Current Assets (2010 - 2026)

Cytosorbents has reported Other Non-Current Assets for 17 years, with the latest figure at $52000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets fell 98.62% year-over-year to $52000.0; the trailing twelve-month figure through Mar 2026 stood at $52000.0 (down 98.62% YoY), and the FY2025 full-year result was $53000.0, up 6.0% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $52000.0, down from $53000.0 in the prior quarter.
• The five-year high for Other Non-Current Assets was $6.5 million in Q2 2024, with the low at $50000.0 in Q4 2024.
• Historically, Other Non-Current Assets has averaged $2.2 million across 5 years, with a median of $1.7 million in 2022.
• Annual changes were most pronounced in 2024 — Other Non-Current Assets soared 284.24% — and 2026, when it sank 98.62%.
• Cytosorbents' Other Non-Current Assets stood at $4.4 million in 2022, then slumped by 66.56% to $1.5 million in 2023, then plunged by 96.63% to $50000.0 in 2024, then climbed by 6.0% to $53000.0 in 2025, then slipped by 1.89% to $52000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $52000.0 (Q1 2026), $53000.0 (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.